Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Molecular Imaging and Biology|July 31, 2008
FDG-PET/CT for the evaluation of response to therapy of cutaneous T-cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trialPhillip H Kuo, Kacie R Carlson, Inger Christensen, et al.Cancers|September 14, 2024
Clinical and Histologic Variants of CD8+ Cutaneous T-Cell LymphomasMadisen A Swallow, Goran Micevic, Amanda Zhou, et al.Journal of Cutaneous Pathology|September 21, 2010
A transient epidermolysis bullosa simplex-like phenotype associated with bexarotene treatment in a G138E KRT5 heterozygoteJoshua W Trufant, Gretchen M Kreizenbeck, Kacie R Carlson, et al.Nature Communications|January 15, 2024
Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancyJingjing Ren, Xiaofeng Liao, Julia M Lewis, et al.Blood|October 4, 2017
Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patientsBenoit M Cyrenne, Julia M Lewis, Jason G Weed, et al.Oncotarget|July 19, 2018
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibitionSa Rang Kim, Julia M Lewis, Benoit M Cyrenne, et al.Journal of the American Academy of Dermatology|February 15, 2016
Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restrictionJuliet F Gibson, Jing Huang, Kristina J Liu, et al.Blood Advances|May 22, 2020
JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCLSara Yumeen, Fatima N Mirza, Julia M Lewis, et al.The Journal of Investigative Dermatology|September 2, 2011
Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patientsWilliam M Lin, Julia M Lewis, Renata B Filler, et al.Blood Advances|August 10, 2022
Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populationsJingjing Ren, Rihao Qu, Nur-Taz Rahman, et al.Pageof 1